Moreover, immunotherapies such as IL-15 cytokine therapy in combination with TIGIT blockade therapy (5) as well as PD-1 and CTLA-4 inhibitors (6) have made progress in treating patients with STS. The gene discussed is PDCD1; the disease is telomere syndrome.